• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Why are oseltamivir and zanamivir effective against the newly emerged influenza A virus (A/H1N1)?

作者信息

Yu Kunqian, Luo Cheng, Qin Guangrong, Xu Zhijian, Li Ning, Liu Hong, Shen Xu, Ma Jianpeng, Wang Qinghua, Yang Caiguang, Zhu Weiliang, Jiang Hualiang

出版信息

Cell Res. 2009 Oct;19(10):1221-4. doi: 10.1038/cr.2009.111. Epub 2009 Sep 22.

DOI:10.1038/cr.2009.111
PMID:19770846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7091778/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6d0/7091778/d1aff9adc707/41422_2009_Article_BFcr2009111_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6d0/7091778/d1aff9adc707/41422_2009_Article_BFcr2009111_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6d0/7091778/d1aff9adc707/41422_2009_Article_BFcr2009111_Fig1_HTML.jpg

相似文献

1
Why are oseltamivir and zanamivir effective against the newly emerged influenza A virus (A/H1N1)?为什么奥司他韦和扎那米韦对新出现的甲型流感病毒（A/H1N1）有效？
Cell Res. 2009 Oct;19(10):1221-4. doi: 10.1038/cr.2009.111. Epub 2009 Sep 22.
2
Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.探究奥司他韦（达菲）与2009年甲型H1N1流感病毒神经氨酸酶相互作用的见解。
Biochem Biophys Res Commun. 2009 Aug 28;386(3):432-6. doi: 10.1016/j.bbrc.2009.06.016. Epub 2009 Jun 10.
3
Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.长效神经氨酸酶抑制剂拉尼米韦对 H5N1 亚型和大流行 H1N1 流感病毒的结合模式。
J Mol Graph Model. 2012 Sep;38:148-54. doi: 10.1016/j.jmgm.2012.06.007. Epub 2012 Jul 4.
4
Antiviral drugs for influenza 2012-2013.2012 - 2013年流感抗病毒药物
Med Lett Drugs Ther. 2012 Dec 10;54(1405):97-8.
5
Recent advances in neuraminidase inhibitor development as anti-influenza drugs.神经氨酸酶抑制剂作为抗流感药物的研究进展。
ChemMedChem. 2012 Sep;7(9):1527-36. doi: 10.1002/cmdc.201200155. Epub 2012 Jul 16.
6
A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor".小分子化合物通过充当“PB2 抑制剂”发挥抗甲型流感病毒活性。
Mol Pharm. 2018 Sep 4;15(9):4110-4120. doi: 10.1021/acs.molpharmaceut.8b00531. Epub 2018 Aug 23.
7
Binding mode analysis of anti-influenza drugs in H1N1 (2009) and H5N1 influenza A virus and designing of potential H1N1 inhibitors.抗流感药物在甲型H1N1（2009）和H5N1流感病毒中的结合模式分析及潜在H1N1抑制剂的设计
Int J Comput Biol Drug Des. 2015;8(1):1-18. doi: 10.1504/IJCBDD.2015.068753. Epub 2015 Apr 13.
8
Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.甲型禽流感病毒H5N1亚型神经氨酸酶与奥司他韦、扎那米韦、帕拉米韦及其膦酸酯类似物复合物的动态行为
J Chem Inf Model. 2009 Oct;49(10):2323-32. doi: 10.1021/ci900277r.
9
Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.2014年丹麦甲型（H1N1）pdm09流感病毒中对奥司他韦和扎那米韦耐药性的演变
Euro Surveill. 2017 Jan 19;22(3). doi: 10.2807/1560-7917.ES.2017.22.3.30445.
10
A surface plasmon resonance assay for measurement of neuraminidase inhibition, sensitivity of wild-type influenza neuraminidase and its H274Y mutant to the antiviral drugs zanamivir and oseltamivir.一种用于测量神经氨酸酶抑制作用、野生型流感神经氨酸酶及其H274Y突变体对抗病毒药物扎那米韦和奥司他韦敏感性的表面等离子体共振测定法。
J Mol Recognit. 2015 Sep;28(9):521-7. doi: 10.1002/jmr.2467. Epub 2015 Mar 2.

引用本文的文献

1
Comparative study of Danshen and Siwu decoction based on the molecular structures of the components and predicted targets.基于成分和预测靶点的分子结构对丹参和四物汤的比较研究。
BMC Complement Med Ther. 2021 Jan 22;21(1):42. doi: 10.1186/s12906-021-03209-1.
2
SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.SARS-CoV-2 进化适应宿主进入和识别病毒-宿主相互作用中受体 O-乙酰神经氨酸糖基化。
Int J Mol Sci. 2020 Jun 26;21(12):4549. doi: 10.3390/ijms21124549.
3
Applying high-performance computing in drug discovery and molecular simulation.

本文引用的文献

1
On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).基于结构的甲型H5N1流感病毒神经氨酸酶（NA）新型抑制剂的设计
Biophys Chem. 2009 Mar;140(1-3):35-8. doi: 10.1016/j.bpc.2008.11.004. Epub 2008 Nov 20.
2
Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir.季节性H1N1流感病毒神经氨酸酶的酶学特性为对奥司他韦产生天然抗性的出现提供了见解。
PLoS Pathog. 2008 Jul 25;4(7):e1000103. doi: 10.1371/journal.ppat.1000103.
3
Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV).
将高性能计算应用于药物发现和分子模拟。
Natl Sci Rev. 2016 Mar;3(1):49-63. doi: 10.1093/nsr/nww003. Epub 2016 Jan 11.
4
Post-Glycosylation Modification of Sialic Acid and Its Role in Virus Pathogenesis.唾液酸的糖基化后修饰及其在病毒致病机制中的作用
Vaccines (Basel). 2019 Nov 1;7(4):171. doi: 10.3390/vaccines7040171.
5
Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase.针对 H1N1 流感病毒神经氨酸酶的新型天然多环化合物的计算研究。
J Mol Model. 2012 Aug;18(8):3445-53. doi: 10.1007/s00894-011-1349-0. Epub 2012 Jan 27.
6
Molecular basis of NDM-1, a new antibiotic resistance determinant.NDM-1 的分子基础，一种新的抗生素耐药决定簇。
PLoS One. 2011;6(8):e23606. doi: 10.1371/journal.pone.0023606. Epub 2011 Aug 24.
7
Receptor recognition mechanism of human influenza A H1N1 (1918), avian influenza A H5N1 (2004), and pandemic H1N1 (2009) neuraminidase.人甲型流感 H1N1（1918 年）、甲型禽流感 H5N1（2004 年）和人流感 H1N1（2009 年）神经氨酸酶的受体识别机制。
J Mol Model. 2012 Jan;18(1):285-93. doi: 10.1007/s00894-011-1071-y. Epub 2011 Apr 27.
8
Molecular modeling, docking and dynamics simulations of GNA-related lectins for potential prevention of influenza virus (H1N1).GNA 相关凝集素的分子建模、对接和动力学模拟，用于预防流感病毒（H1N1）。
J Mol Model. 2012 Jan;18(1):27-37. doi: 10.1007/s00894-011-1022-7. Epub 2011 Mar 29.
9
Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.奥司他韦在季节性、禽流感 H5N1 和大流行 2009 年 A/H1N1 流感中的药代动力学和药效学特征。
Clin Pharmacokinet. 2010 Nov;49(11):741-65. doi: 10.2165/11534730-000000000-00000.
对甲型H5N1流感病毒神经氨酸酶（NA）对奥司他韦（OTV）耐药性分子机制的再审视。
Biophys Chem. 2008 Aug;136(2-3):152-8. doi: 10.1016/j.bpc.2008.06.003. Epub 2008 Jun 14.
4
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants.耐奥司他韦流感病毒神经氨酸酶突变体的晶体结构
Nature. 2008 Jun 26;453(7199):1258-61. doi: 10.1038/nature06956. Epub 2008 May 14.
5
Influenza viruses and the evolution of avian influenza virus H5N1.流感病毒与禽流感病毒H5N1的进化
Int J Infect Dis. 2008 May;12(3):233-8. doi: 10.1016/j.ijid.2007.07.002. Epub 2007 Oct 2.
6
A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission.1918年流感病毒血凝素中的两个氨基酸变化会消除传播能力。
Science. 2007 Feb 2;315(5812):655-9. doi: 10.1126/science.1136212.
7
An overview of the epidemiology of avian influenza.禽流感流行病学概述。
Vaccine. 2007 Jul 26;25(30):5637-44. doi: 10.1016/j.vaccine.2006.10.051. Epub 2006 Nov 9.
8
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.H5N1禽流感神经氨酸酶的结构为药物设计提供了新机遇。
Nature. 2006 Sep 7;443(7107):45-9. doi: 10.1038/nature05114. Epub 2006 Aug 16.
9
Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors.抗病毒耐药流感病毒对新型神经氨酸酶抑制剂的敏感性。
Antimicrob Agents Chemother. 2005 Nov;49(11):4515-20. doi: 10.1128/AAC.49.11.4515-4520.2005.
10
Characterization of the 1918 influenza virus polymerase genes.1918年流感病毒聚合酶基因的特性研究
Nature. 2005 Oct 6;437(7060):889-93. doi: 10.1038/nature04230.